scholarly journals Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study

2021 ◽  
Author(s):  
Hui-Ching Hsu ◽  
Yu-Sheng Chang ◽  
Tsung-Yun Hou ◽  
Lung-Fang Chen ◽  
Li-Fang Hu ◽  
...  
Keyword(s):  
Rheumatic Diseases ◽  
Population Based ◽  
Pneumocystis Jirovecii ◽  
Pneumocystis Jirovecii Pneumonia ◽  
Population Based Study ◽  
Autoimmune Rheumatic Diseases

scholarly journals Increased risks of autoimmune rheumatic diseases in patients with psoriasis: A nationwide population-based study

2018 ◽  
Vol 79 (4) ◽  
pp. 778-781
Author(s):  
Hyun Jeong Ju ◽  
Ki-Jo Kim ◽  
Dae Suk Kim ◽  
Ji Hae Lee ◽  
Gyung Moon Kim ◽  
...  
Keyword(s):  
Rheumatic Diseases ◽  
Population Based ◽  
Population Based Study ◽  
Autoimmune Rheumatic Diseases

Prevalence and incidence in patients with autoimmune rheumatic diseases: A nationwide population-based study in Taiwan

2013 ◽  
Vol 65 (2) ◽  
pp. 244-250 ◽  
Author(s):  
Kuang-Hui Yu ◽  
Lai-Chu See ◽  
Chang-Fu Kuo ◽  
I-Jun Chou ◽  
Meng-Jiun Chou
Keyword(s):  
Rheumatic Diseases ◽  
Population Based ◽  
Population Based Study ◽  
Autoimmune Rheumatic Diseases

scholarly journals Pneumocystis jirovecii Pneumonia in Patients with Rheumatic Diseases: Risk Assessment and Prophylaxis

2022 ◽  
pp. 1-7
Author(s):  
Matthew Shing Him Lee ◽  
Shirley Chiu Wai Chan
Keyword(s):  
Risk Factors ◽  
Risk Assessment ◽  
Rheumatic Diseases ◽  
Immunosuppressive Agents ◽  
Pneumocystis Jirovecii ◽  
Pneumocystis Jirovecii Pneumonia ◽  
International Guideline ◽  
Related Factors ◽  
Factors Associated ◽  
Disease Specific

Pneumocystis jirovecii pneumonia (PJP) is an uncommon opportunistic infection in patients with rheumatic diseases with high mortality. Unlike other non-HIV conditions, international guideline for PJP prophylaxis in rheumatic diseases is currently lacking. Recent evidence regarding the risk of PJP and effectiveness of prophylaxis has been accumulating. This Review provides an update on the information about risk factors associated with PJP in patients with rheumatic diseases based on rheumatic diagnoses, use of immunosuppressive agents and other disease-related factors. The second part of the article summarizes evidence regarding the effectiveness of PJP prophylaxis by considering both disease-related and therapy-related factors. Finally, the Review outlined the currently available disease-specific recommendations and local guidelines, and appreciate the factors that influence physicians’ decision.

scholarly journals Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study

PLoS ONE ◽  
2018 ◽  
Vol 13 (7) ◽  
pp. e0201340 ◽  
Author(s):  
Hsin-Hua Chen ◽  
Wen-Cheng Chao ◽  
Tsai-Ling Liao ◽  
Ching-Heng Lin ◽  
Der-Yuan Chen
Keyword(s):  
Cohort Study ◽  
Rheumatic Diseases ◽  
Population Based ◽  
Palindromic Rheumatism ◽  
Autoimmune Rheumatic Diseases

The Accuracy of Administrative Data Diagnoses of Systemic Autoimmune Rheumatic Diseases

2011 ◽  
Vol 38 (8) ◽  
pp. 1612-1616 ◽  
Author(s):  
SASHA BERNATSKY ◽  
TINA LINEHAN ◽  
JOHN G. HANLY
Keyword(s):  
Rheumatic Disease ◽  
Administrative Data ◽  
Rheumatic Diseases ◽  
Lupus Erythematosus ◽  
Population Based ◽  
Administrative Database ◽  
Case Definitions ◽  
Autoimmune Rheumatic Diseases ◽  
Specificity And Sensitivity ◽  
Clinical Records

Objective.To examine the validity of case definitions for systemic autoimmune rheumatic diseases [SARD; systemic lupus erythematosus (SLE), systemic sclerosis (SSc), myositis, Sjögren’s syndrome, vasculitis, and polymyalgia rheumatica] based on administrative data, compared to rheumatology records.Methods.A list of rheumatic disease diagnoses was generated from population-based administrative billing and hospitalization databases. Subjects who had been seen by an arthritis center rheumatologist were identified, and the medical records reviewed.Results.We found that 844 Nova Scotia residents had a diagnosis of one of the rheumatic diseases of interest, based on administrative data, and had had ≥ 1 rheumatology assessment at a provincial arthritis center. Charts were available on 824 subjects, some of whom had been identified in the administrative database with > 1 diagnosis. Thus a total of 1136 diagnoses were available for verification against clinical records. Of the 824 subjects, 680 (83%) had their administrative database diagnoses confirmed on chart review. The majority of subjects who were “false-positive” for a given rheumatic disease on administrative data had a true diagnosis of a similar rheumatic disease. Most sensitivity estimates for specific administrative data-based case definitions were > 90%, although for SSc, the sensitivity was 80.5%. The specificity estimates were also > 90%, except for SLE, where the specificity was 72.5%.Conclusion.Although health administrative data may be a valid resource, there are potential problems regarding the specificity and sensitivity of case definitions, which should be kept in mind for future studies.

Sign in / Sign up

Export Citation Format

Share Document